Neutralizing antibodies are known to have a crucial role in protecting against SARS-CoV-2
infection and have been suggested to be a useful correlate of protection for vaccine clinical …

The treatment for COVID-19 has evolved rapidly since the start of the pandemic and now
consists mainly of antiviral and immunomodulatory agents. Antivirals, such as remdesivir …

Despite the success of COVID-19 vaccines, severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) variants of concern have emerged that can cause breakthrough infections …

The world is in need of next-generation COVID-19 vaccines. Although first-generation
injectable COVID-19 vaccines continue to be critical tools in controlling the current global …

Whole virion inactivated vaccine CoronaVac (C) and Spike (S) mRNA BNT162b2 (B)
vaccines differ greatly in their ability to elicit neutralizing antibodies but have somewhat …

The effectiveness of neutralizing monoclonal antibodies against emerging variants with
spike protein mutations has been limited. Early high-titer convalescent plasma therapy …

Background There is a need to understand the relationship between COVID-19
Convalescent Plasma (CCP) anti-SARS-CoV-2 IgG levels and clinical outcomes to optimize …

SARS-CoV-2, the etiological agent behind the coronavirus disease 2019 (COVID-19)
pandemic, has continued to mutate and create new variants with increased resistance …

Immunocompromised patients are at high risk to fail clearance of SARS‐CoV‐2. Prolonged
COVID‐19 constitutes a health risk and a management problem as cancer treatments often …

Cordyceps sinensis (CS) has been widely used as a dietary supplement or traditional
medicine for the prevention, treatment, and prognostication of various diseases, because of …